XIFAXAN (Avera McKennan Hospital)


Welcome to the PulseAid listing for the XIFAXAN drug offered from Avera McKennan Hospital. This Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: rifaximin
SUBSTANCE NAME: RIFAXIMIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


XIFAXAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXIFAXAN from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0309_36bc6a96-544d-4b0b-937d-323e308da080
PRODUCT NDC: 69189-0309
APPLICATION NUMBER: NDA021361

Other RIFAXIMIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalXIFAXAN
Cardinal HealthXIFAXAN
Carilion Materials ManagementXIFAXAN
Dispensing Solutions, Inc.XIFAXAN
Physicians Total Care, Inc.XIFAXAN
Salix Pharmaceuticals, Inc.XIFAXAN